Key result
Letter reviews statin effects on coronary and valvular calcification without providing new quantitative data.
Why the study?
Coronary and heart valve calcifications reflect atherosclerosis and predict cardiovascular events, but the clinical significance of statins on these calcifications remains unclear.
CT-detected vascular calcifications predict events and mortality; leaves open incremental value for risk stratification in practice.
Coronary artery calcification (CAC), aortic valve calcification (AVC), aortic root, mitral valve calcification (MVC) and thoracic aorta calcification, identified and quantified by computed tomography (CT) imaging, reflect atherosclerosis disease and predict cardiovascular events (stable angina, acute coronary syndromes) and mortality.1–3 Non-invasive CT imaging provides information on the coronary wall, atherosclerotic plaque, spotty calcification, defining the ‘high-risk’ plaque status associated with acute coronary syndromes. Recently, Lee et al. in the PARADIGM study showed that statins were associated with slower progression of coronary plaque, increasing plaque calcium volume and reducing high-risk plaque features by phenotypic plaque transformation.4 We previously commented on the data of Lee et al...
No takes yet. Share an insight, caveat, or question.
Mazzone et al. (2020) conducted a letter in Primary cardiovascular prevention. Statins was evaluated. The association of statins with calcification in coronary plaque and heart valves was discussed, but no quantitative results from the MHELP study were reported in the abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: